If the page does not redirect, click here
New MS drug could slow symptoms of 'untreatable' form of disease
Siponimod offers hope for people with secondary progressive MS, in which disabilities get worse over timeA new drug for multiple sclerosis could slow the progression of symptoms of a form of the disease for which effective treatments have proved elusive, research suggests.It is thought about 100,000 people in the UK and 2,500,000 people worldwide have MS, a neurological condition that can affect speech, movement of limbs and vision, among other things.